We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -2.00% | 12.25 | 12.00 | 12.50 | 12.50 | 12.25 | 12.50 | 553,192 | 13:40:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -1.47 | 31.92M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/10/2022 10:34 | i suggest everyone email investor relations at AGL ...Give them your thoughts !!! | amaretto1 | |
18/10/2022 10:30 | Filtered for being a ignorant PIG !!!! | amaretto1 | |
18/10/2022 10:24 | Oh dear somenposters looking like fools again after that RNs. The fact they are already concerned about the cash runway shows they are not making progress very fast and are now likely to run out of cash yet again before getting anywhere near break even . For this to turn they need to sign big deals with numbers that the city can use to see how long they have to wait before breaking even. Who would have thought after FDA approval they are back in the 40's just shows what a mess AN has made of running the company . Great scientist poor CEO imo . | bones698 | |
18/10/2022 10:23 | So if there is a distressed seller, why are the company’s broker not in contact with them in order to do a clean out transaction to place the stock in firm institutional hands? | henley2 | |
18/10/2022 10:20 | I'm still waiting for management to tell me when to buy, I stopped buying when they told me they didn't want shareholders making money around the 150p level | che7win | |
18/10/2022 10:16 | Just like it didnt record the last time it dropped this low? Muppet | zeus19 | |
18/10/2022 10:15 | Yawn, youre a broken record | zeus19 | |
18/10/2022 10:12 | 74Tom, get a grip and stop running around the playground screaming. There are a number of distressed sellers in the market and they need to turn their assets liquid. You're imagination is running wild. No amount of good news will turn the share price until they have exhausted their sales. I've just bought 15000 and it went through as a sell. | hairballradical | |
18/10/2022 10:12 | Heading further south, FFS! | vatnabrekk | |
18/10/2022 10:10 | At 49.6p the enterprise value (market cap less cash) is less than $100m. And it has now gone below that. Totally ripe for a takeover offer at the moment. | sicilian_kan | |
18/10/2022 10:09 | The mkt madness continues - at this rate I'm going to need to top up | spaceparallax | |
18/10/2022 10:09 | 74Tom, are you suggesting that the day after tax credits removal are announced you close down a whole operation without discussion with the team in Canada and put everyone out onto the street? These things take months to sort out, no doubt the govt would have been involved for discussions on potential R&D tax breaks over there. So actually this has been done phenomenally quickly and the board deserve great praise. Same R&D functions being undertaken, significant cash savings and no doubt greater control over which R&D is done and how that money was being spent. Well done to the board. | hairballradical | |
18/10/2022 10:06 | Relentless selling after a 'good RNS'. Maybe the '3 BIG COMPANIES' they talked to have walked away and not interested. Be prepared to receive news distribution agreement in Uganda. What an achievement! | deanmatlazin | |
18/10/2022 10:04 | Yes it was mentioned | amaretto1 | |
18/10/2022 10:04 | And I didn't say it shouldn't be RNS'd, just that it shouldn't be released on it's own. The interims were released 12 days ago and no mention was made of this change, that's the problem here and why the share price is tumbling. | 74tom | |
18/10/2022 10:01 | Bagpuss, this was just posted on LSE; "Concerning announcement. Suggests lack of grip from Board and CEO. These tax credit changes were published in July. So why wasn’t this flagged at the Interims? Nothing new has happened since the interims for the Board to consider this change - unless they are becoming increasingly concerned on cash. Seems to me the CEO doesn't have a proper strategy - except for spray and pray." | 74tom | |
18/10/2022 09:40 | Bagpuss, as I have stated before I’m a long term shareholder here. When Jupiter dumped their position a few years ago and the share price collapsed to 40p, FDA approval had not been achieved, unlike now. I wish I did have a short SB, but alas not. AN talks a great deal about multi-billion dollar market opportunities, is He and the current Board the right people to achieve it? Market says NO, hence the need for a change in personnel, starting with a refresh of the Board. | henley2 | |
18/10/2022 09:39 | The closure had to be RNSd. Otherwise news of redundancies would have appeared anyway. Best to explain before. | purchaseatthetop | |
18/10/2022 09:31 | I strongly suggest ignoring serial rampers like AMARETTO and PURCHASE. I maintain that if this breaks the 50p barrier it will then plummet rapidly like many of the other super ramped stocks recommended by PURCHASE. The only hope will then be for a takeover well below 80p IMO. AN had such an amazing product here but clearly didn’t know how to market it. | antonagis |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions